Biomarkers in Diagnostics & Therapeutics 2011

The global biomarker market is estimated to be $20.5 billion by 2014. This figure could be underestimated, looking at the potential of biomarkers to improve drug success while facilitating co-development with clinical diagnostics for disease prediction. BDT2011 will discuss values of biomarker applications and examine their potential to drive developments in genomics medicine and personalized healthcare.

KEY TOPICS:
• Biomarkers propelling developments in molecular diagnostics
• Biomarkers streamlining the process of drug discovery & development
• Biomarkers in the co-development of drugs & diagnostics
• Predictive biomarkers: Enabling preemptive actions in disease development
• Advancing biomarker discovery & validation
• Gearing up for the marathon of personalized medicine

Quote 11001BVT to enjoy 15% savings on standard registration fees